Clendeninn Nj

Statistics

Publications

Citations

223

H-Index

Active since

1984

Affiliations

National Cancer Institute(Current)

Clendeninn Nj is an author at National Cancer Institute specializing in pharmacology, pharmacokinetics in children with cancer, and pharmacokinetics of anticancer drugs.

Publications per year

1984–1990

Publications

Drug resistance in cancer.

Curt Ga, Clendeninn Nj, Chabner Ba · PubMed · 1984 · 172 citations

Medicine, Oncology, Pharmacology +12

Pediatric phase I trial and pharmacokinetic study of piritrexim administered orally on a five-day schedule.

Adamson Pc, Frank M. Balis, J. Miser et al. · PubMed · 1990 · 18 citations

Pharmacy, Pediatrics, Pharmacology +17

Preclinical biochemical pharmacology and toxicology of piritrexim, a lipophilic inhibitor of dihydrofolate reductase.

Sigel Cw, Macklin Aw, Woolley Jl et al. · PubMed · 1987 · 17 citations

Medicine, Pharmacokinetics, Pharmacology +15

Initial clinical studies of piritrexim.

John László, Brenckman Wd, E. W. Morgan et al. · PubMed · 1987 · 16 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

1–4 of 4